{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:01:29Z","timestamp":1773813689858,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.imbio.2026.153171","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T23:33:46Z","timestamp":1771716826000},"page":"153171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and risk factors of dyslipidemia in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"231","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2026.153171_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115162","article-title":"Toward immune tolerance in rheumatoid arthritis: emerging immunotherapies and targets for long-term remission","volume":"162","author":"Afshari","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153171_bb0010","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.jacl.2024.05.005","article-title":"Dyslipidemia management in women of reproductive potential: an Expert Clinical Consensus from the National Lipid Association","volume":"18","author":"Agarwala","year":"2024","journal-title":"J. Clin. Lipidol."},{"issue":"10","key":"10.1016\/j.imbio.2026.153171_bb0015","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1007\/s10067-025-07644-0","article-title":"Transforming rheumatoid arthritis care: dynamic budget impact models with ACR to DAS28 mapping for anti-TNFs, JAK inhibitors, and interleukins","volume":"44","author":"Al-Jedai","year":"2025","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153171_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.31138\/mjr.310824.cri","article-title":"Cardiovascular risk in rheumatoid arthritis: considerations on assessment and management","volume":"35","author":"Anyfanti","year":"2024","journal-title":"Mediterr. J. Rheumatol."},{"issue":"27","key":"10.1016\/j.imbio.2026.153171_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000043133","article-title":"Efficacy and safety of low-dose rosuvastatin\/ezetimibe for dyslipidemia in patients with rheumatoid arthritis or osteoarthritis","volume":"104","author":"Bak","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.imbio.2026.153171_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1594218","article-title":"The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and rheumatoid arthritis: a cross-sectional study","volume":"12","author":"Deng","year":"2025","journal-title":"Front. Nutr."},{"issue":"10","key":"10.1016\/j.imbio.2026.153171_bb0035","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imbio.2026.153171_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2022.11.006","article-title":"Exploring potential shared genetic influences between rheumatoid arthritis and blood lipid levels","volume":"363","author":"Kasher","year":"2022","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.imbio.2026.153171_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11886-025-02198-8","article-title":"Cardiovascular risk factor and atherosclerosis in Rheumatoid Arthritis (RA)","volume":"27","author":"Kattamuri","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"issue":"Suppl. 6","key":"10.1016\/j.imbio.2026.153171_bb0055","first-page":"vi5","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.imbio.2026.153171_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.102020","article-title":"Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up","volume":"39","author":"Misra","year":"2025","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.imbio.2026.153171_bb0070","series-title":"Dyslipidemia","author":"Pappan","year":"2025"},{"issue":"1","key":"10.1016\/j.imbio.2026.153171_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-025-02495-9","article-title":"Non-linear associations between blood glucose, blood lipids and inflammatory markers and new-onset arthritis in the middle-aged and older population - a cohort study in Europe","volume":"24","author":"Qiu","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.imbio.2026.153171_bb0080","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10067-025-07364-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis","volume":"44","author":"Saidi","year":"2025","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153171_bb0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s13679-023-00520-5","article-title":"Obesity, Metabolic Syndrome, and Osteoarthritis-an Updated Review","volume":"12","author":"Sampath","year":"2023","journal-title":"Curr. Obes. Rep."},{"issue":"2","key":"10.1016\/j.imbio.2026.153171_bb0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/CRD.0000000000000486","article-title":"Cardiovascular Manifestations in Rheumatoid Arthritis","volume":"32","author":"Sanghavi","year":"2024","journal-title":"Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.imbio.2026.153171_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2025.102036","article-title":"A review on the epidemiology of rheumatoid arthritis: an update and trends from current literature","volume":"39","author":"Uke","year":"2025","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"8","key":"10.1016\/j.imbio.2026.153171_bb0100","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s10067-024-07040-0","article-title":"Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"43","author":"Wang","year":"2024","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.imbio.2026.153171_bb0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/art.43105","article-title":"Immune Aging in Rheumatoid Arthritis","volume":"77","author":"Weyand","year":"2025","journal-title":"Arthritis Rheum."},{"issue":"20","key":"10.1016\/j.imbio.2026.153171_bb0110","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical, A","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.imbio.2026.153171_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1254753","article-title":"Dyslipidemia in rheumatoid arthritis: the possible mechanisms","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153171_bb0120","article-title":"Engineered Spirulina platensis for treating rheumatoid arthritis and restoring bone homeostasis","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:04:04Z","timestamp":1773810244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0171298526000173"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153171","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors of dyslipidemia in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153171"}}